Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$17.26

3.39 (24.44%)

13:33
03/26/19
03/26
13:33
03/26/19
13:33

Bed Bath & Beyond responds to 'public attack' from activist group

Bed Bath & Beyond issued the following statement in response to a press release issued by Legion Partners Asset Management, Macellum Advisors and Ancora Advisors regarding the activist group's submission of 16 nominees to take over the board at the company's 2019 Annual Meeting of Shareholders: "Bed Bath & Beyond regularly engages with our shareholders and welcomes constructive input focused on enhancing value. Members of our board of directors and senior management team have met with and held several discussions with Legion and Macellum over the past few weeks. Ancora has not previously reached out to or engaged with the company. In these conversations, we made clear our commitment to engaging constructively and acting in the best interest of all Bed Bath & Beyond shareholders. We asked on several occasions for their suggestions and ideas for improving the company's business but they did not provide any. We also invited them to participate in the board refreshment program we have been undertaking in recent years and are in the process of accelerating with investor input. Instead they chose to publicly attack the company and provide their intent to nominate directors to take over the full board. Unfortunately, while our directors and management were seeking to engage in good faith, it appears that the Legion and Macellum representatives were merely seeking information to support their attack. Bed Bath & Beyond is undertaking a comprehensive transformation to evolve the foundational structure of the business, drive shareholder value and best position the company for long-term success. While the activist group has not provided any specific recommendations despite the company's repeated requests, we note that many of the areas highlighted by the activist group in its press release are already being addressed at a detailed level by the company. We look forward to receiving and reviewing any specific suggestions and recommendations the activist group may have... Bed Bath & Beyond has a diverse, experienced board of directors that is committed to acting in the best interest of all shareholders and supporting the company's strategic priorities. The board includes 12 highly qualified directors, all of whom are actively engaged and possess significant experience relevant to our business. The board recognizes the value of fresh perspectives and diversity in the boardroom and regularly evaluates its composition to ensure it reflects the right mix of skills and expertise. Notably, as part of the board's ongoing refreshment program, three new independent directors with relevant experience have been added during the last two years... The Nominating and Corporate Governance Committee and the board are responsible for evaluating director candidates qualified to become members of the board, and will do so consistent with established processes."

  • 10

    Apr

BBBY Bed Bath & Beyond
$17.26

3.39 (24.44%)

03/26/19
03/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) upgraded to Strong Buy from Market Perform at Raymond James , to Hold from Sell at Loop Capital, and to Sector Weight from Underweight at KeyBanc. 2. BB&T (BBT) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying after meeting with CEO of SunTrust (STI), he remains positive on the merger and the combined stock. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at William Blair with analyst Y. Katherine Xu citing expectations that the company's cystic fibrosis franchise will continue dominating after Proteostasis (PTI) reported disappointing triplet data. 4. Allegiant Travel (ALGT) upgraded to Outperform from Neutral at Macquarie with analyst Susan Donofrio citing her meetings with its management last week. 5. TransAlta (TAC) upgraded to Buy from Hold at TD Securities with analyst John Mould saying Brookfield Renewable Partners (BEP) $750M investment in TransAlta improves the company's financial flexibility, accelerates its ability to return capital to shareholders and advance the coal-to-gas conversion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/26/19
BOFA
03/26/19
UPGRADE
BOFA
Buy
Bed Bath & Beyond upgraded to Buy from Underperform at BofA/Merrill
03/26/19
BOFA
03/26/19
UPGRADE
Target $21
BOFA
Buy
BofA/Merrill double upgrades Bed Bath & Beyond to Buy on activist involvement
BofA/Merrill Lynch analyst Curtis Nagle upgraded Bed Bath & Beyond two notches, to Buy from Underperform, following the announcement that activist investors holding a 5% stake are launching a proxy fight to replace the company's senior management and its entire board. While he is still cautious on the retailer's ability to significantly improve gross profit dollars, Nagle said the proxy fight "at the very least puts significantly more pressure" on the company to turn around results and profitability. The analyst, who sees the biggest opportunities in cost reductions, store closures and value creation from secondary concepts, raised his price target on Bed Bath shares to $21 from $11.
03/26/19
JPMS
03/26/19
UPGRADE
JPMS
Neutral
Bed Bath & Beyond upgraded to Neutral from Underweight at JPMorgan

TODAY'S FREE FLY STORIES

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary  »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$82.69

1.85 (2.29%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
06/25/19
06/25
13:25
06/25/19
13:25
General news
Fed Chair Powell repeated the phrase from the FOMC that the Fed is "closely monitoring »

Fed Chair Powell repeated…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

, ETFC

E-Trade

$44.43

-0.14 (-0.31%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

ETFC

E-Trade

$44.43

-0.14 (-0.31%)

SCHW

Charles Schwab

$39.22

0.07 (0.18%)

AMTD

TD Ameritrade

$48.32

0.23 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

13:20
06/25/19
06/25
13:20
06/25/19
13:20
General news
FX Action: The DXY rallied »

FX Action: The DXY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/25/19
06/25
13:17
06/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/25/19
06/25
13:16
06/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$23.90

-1.52 (-5.98%)

13:15
06/25/19
06/25
13:15
06/25/19
13:15
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/25/19
06/25
13:15
06/25/19
13:15
General news
Treasury's $40 B 2-year auction was mixed as a confluence of factors impacted »

Treasury's $40 B…

ASOMY

Asos

$0.00

(0.00%)

13:11
06/25/19
06/25
13:11
06/25/19
13:11
Downgrade
Asos rating change  »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$33.46

0.28 (0.84%)

13:08
06/25/19
06/25
13:08
06/25/19
13:08
On The Fly
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

13:08
06/25/19
06/25
13:08
06/25/19
13:08
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:07
06/25/19
06/25
13:07
06/25/19
13:07
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

MDR

McDermott

$8.82

0.6 (7.30%)

13:05
06/25/19
06/25
13:05
06/25/19
13:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.48

-0.24 (-0.42%)

13:03
06/25/19
06/25
13:03
06/25/19
13:03
Hot Stocks
Oracle announces 'simplified' analytics product offering »

Oracle said in a press…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.03

0.82 (1.94%)

12:55
06/25/19
06/25
12:55
06/25/19
12:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
06/25/19
06/25
12:55
06/25/19
12:55
General news
Fed dove, and dissenter Bullard doesn't believe a 50 bp easing is necessary right now »

Fed dove, and dissenter…

AGN

Allergan

$163.79

34.14 (26.33%)

, ABBV

AbbVie

$66.51

-11.905 (-15.18%)

12:50
06/25/19
06/25
12:50
06/25/19
12:50
Upgrade
Allergan, AbbVie rating change at Barclays »

Allergan upgraded to…

AGN

Allergan

$163.79

34.14 (26.33%)

ABBV

AbbVie

$66.51

-11.905 (-15.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

AG

First Majestic

$7.98

-0.04 (-0.50%)

12:45
06/25/19
06/25
12:45
06/25/19
12:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
06/25/19
06/25
12:45
06/25/19
12:45
General news
Breaking General news story  »

Federal Reserve Chairman…

DIS

Disney

$139.71

0.49 (0.35%)

12:42
06/25/19
06/25
12:42
06/25/19
12:42
Periodicals
MNC founder says not in talks with Disney over investment, Reuters says »

Media Nusantara Citra is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

APVO

Aptevo Therapeutics

$0.90

-0.0445 (-4.71%)

12:38
06/25/19
06/25
12:38
06/25/19
12:38
Recommendations
Aptevo Therapeutics analyst commentary  »

Aptevo IXINITY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$62.00

-0.76 (-1.21%)

12:37
06/25/19
06/25
12:37
06/25/19
12:37
Recommendations
Teladoc analyst commentary  »

Teladoc CFO hiring news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.